{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:53:18Z","timestamp":1781823198385,"version":"3.54.5"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Duchenne muscular dystrophy (DMD) results from pathogenic variants in the\n                      <jats:italic>DMD<\/jats:italic>\n                      gene. Despite routine screening using Multiplex Ligation-dependent Probe Amplification (MLPA) and Whole-Exome Sequencing (WES), a subset of cases remains molecularly unexplained. This diagnostic gap is often attributed to the inherent limitations of these methods in detecting deep intronic variants or complex structural rearrangements.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We implemented a tiered molecular diagnostic workflow for 10 male patients with suspected DMD. Primary screening for copy number variations (CNVs) was performed via MLPA. Negative cases were sequentially analyzed using WES and Whole-Genome Sequencing (WGS). Pathogenicity was validated through\n                      <jats:italic>in silico<\/jats:italic>\n                      splicing predictions, mRNA transcript analysis, and chromosomal breakpoint mapping.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MLPA identified CNVs in six cases. WES resolved two additional patients, identifying a frameshift variant (c.7392delC) and a nonsense variant (c.4729C&amp;gt;T). In the remaining two cases, WGS identified a deep intronic variant (c.9225\u2013287C&amp;gt;A) and a 9.4\u00a0Mb chromosomal inversion. Functional analysis of the c.9225\u2013287C&amp;gt;A variant revealed the activation of a 58-nucleotide pseudoexon, resulting in a frameshift (p.H3076Vfs*15) and truncated dystrophin expression. For the 9.4\u00a0Mb inversion, WGS successfully mapped the breakpoints to DMD intron 7, enabling definitive carrier identification within the family.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings demonstrate that WGS is a robust tool for detecting pathogenic variations that evade standard MLPA and WES protocols, including deep intronic variants and large-scale inversions. This study emphasizes the clinical necessity of an integrated, tiered genomic approach to ensure accurate genetic counseling and facilitate access to precision therapies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1805459","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:10:25Z","timestamp":1781820625000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Stepwise genetic testing strategy identified pathogenic variants in 10 Chinese duchenne muscular dystrophy patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Dengzhi","family":"Zhao","sequence":"first","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Qi","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixiu","family":"Liao","sequence":"additional","affiliation":[{"name":"Institute of Medical Genetics, Henan Provincial People\u2019s Hospital, People\u2019s Hospital of Zhengzhou University, People\u2019s Hospital of Henan University","place":["Zhengzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/mus.28073","article-title":"Longitudinal data of serum creatine kinase levels and motor, pulmonary, and cardiac functions in 337 patients with Duchenne muscular dystrophy","volume":"69","author":"Awano","year":"2024","journal-title":"Muscle and Nerve"},{"key":"B2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nmeth.3505","article-title":"SpeedSeq: ultra-fast personal genome analysis and interpretation","volume":"12","author":"Chiang","year":"2015","journal-title":"Nat. Methods"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/pd.6201","article-title":"Large scale population screening for duchenne muscular dystrophy-predictable and unpredictable challenges","volume":"42","author":"Cohen","year":"2022","journal-title":"Prenat. Diagnosis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1136\/postgradmedj-2017-135377","article-title":"Duchenne muscular dystrophy: genome editing gives new hope for treatment","volume":"94","author":"Crispi","year":"2018","journal-title":"Postgrad. Medical Journal"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.ymthe.2019.07.012","article-title":"Exons 45-55 skipping using mutation-tailored cocktails of antisense morpholinos in the DMD gene","volume":"27","author":"Echigoya","year":"2019","journal-title":"Mol. Therapy The Journal Am. Soc. Gene Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40246-018-0152-8","article-title":"Molecular characterization of exonic rearrangements and frame shifts in the dystrophin gene in Duchenne muscular dystrophy patients in a Saudi community","volume":"12","author":"Elhawary","year":"2018","journal-title":"Hum. Genomics"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.3390\/ijms23031832","article-title":"CRISPR therapeutics for Duchenne muscular dystrophy","volume":"23","author":"Erkut","year":"2022","journal-title":"Int. Journal Molecular Sciences"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e200251","DOI":"10.1212\/NXG.0000000000200251","article-title":"Association of DMD gene variant classes with motor outcomes in a drug registration clinical trial setting","volume":"11","author":"Fang","year":"2025","journal-title":"Neurol. Genet."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.nmd.2021.08.004","article-title":"The DMD gene and therapeutic approaches to restore dystrophin","volume":"31","author":"Fortunato","year":"2021","journal-title":"Neuromuscul. Disorders NMD"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41431-020-0643-7","article-title":"EMQN best practice guidelines for genetic testing in dystrophinopathies","volume":"28","author":"Fratter","year":"2020","journal-title":"Eur. Journal Human Genetics EJHG"},{"key":"B11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13395-018-0161-2","article-title":"miR-708-5p and miR-34c-5p are involved in nNOS regulation in dystrophic context","volume":"8","author":"Guilbaud","year":"2018","journal-title":"Skelet. Muscle"},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3233\/JND-190431","article-title":"Pseudoexons of the DMD gene","volume":"7","author":"Keegan","year":"2020","journal-title":"J. Neuromuscular Diseases"},{"key":"B13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13023-018-0853-z","article-title":"Comprehensive genetic characteristics of dystrophinopathies in China","volume":"13","author":"Ma","year":"2018","journal-title":"Orphanet Journal Rare Diseases"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/s10038-025-01357-7","article-title":"Molecular genetics of dystrophinopathy","author":"Okubo","year":"2025","journal-title":"J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13023-017-0703-4","article-title":"Comprehensive analysis for genetic diagnosis of dystrophinopathies in Japan","volume":"12","author":"Okubo","year":"2017","journal-title":"Orphanet Journal Rare Diseases"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/s41436-021-01139-4","article-title":"Next-generation sequencing for constitutional variants in the clinical laboratory, 2021 revision: a technical standard of the American college of medical genetics and genomics (ACMG)","volume":"23","author":"Rehder","year":"2021","journal-title":"Genet. Medicine Official Journal Am. Coll. Med. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Medicine Official Journal Am. Coll. Med. Genet."},{"key":"B18","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","article-title":"Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies","volume":"30","author":"Sheikh","year":"2021","journal-title":"Expert Opinion Investigational Drugs"},{"key":"B19","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3390\/genes11080837","article-title":"Therapeutic strategies for Duchenne muscular dystrophy: an update","volume":"11","author":"Sun","year":"2020","journal-title":"Genes"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/s41467-025-56644-w","article-title":"Duchenne muscular dystrophy: recent insights in brain related comorbidities","volume":"16","author":"Vaillend","year":"2025","journal-title":"Nat. Communications"},{"key":"B21","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.ejpn.2016.07.020","article-title":"Why are some patients with Duchenne muscular dystrophy dying young: an analysis of causes of death in north east England","volume":"20","author":"Van Ruiten","year":"2016","journal-title":"Eur. Journal Paediatric Neurology EJPN Official Journal Eur. Paediatr. Neurology Soc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.braindev.2017.03.024","article-title":"The AAV-Mediated and RNA-Guided CRISPR\/Cas9 system for gene therapy of DMD and BMD","volume":"39","author":"Wang","year":"2017","journal-title":"Brain and Development"},{"key":"B23","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fphar.2019.00814","article-title":"Molecular genetics analysis of 70 Chinese families with muscular dystrophy using multiplex ligation-dependent probe amplification and next-generation sequencing","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Pharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e23142","DOI":"10.1002\/jcla.23142","article-title":"Identification of two novel insertion abnormal transcripts in two Chinese families affected with dystrophinopathy","volume":"34","author":"Xu","year":"2020","journal-title":"J. Clinical Laboratory Analysis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1056\/NEJMoa1306555","article-title":"Clinical whole-exome sequencing for the diagnosis of Mendelian disorders","volume":"369","author":"Yang","year":"2013","journal-title":"N. Engl. Journal Medicine"},{"key":"B26","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.humimm.2021.03.011","article-title":"Challenges in the application of NGS in the clinical laboratory","volume":"82","author":"Yin","year":"2021","journal-title":"Hum. Immunology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.4103\/0366-6999.215338","article-title":"A de novo Mutation in Dystrophin Causing Muscular Dystrophy in a Female Patient","volume":"130","author":"Yu","year":"2017","journal-title":"Chin. Medical Journal"},{"key":"B28","doi-asserted-by":"publisher","first-page":"12710","DOI":"10.3390\/ijms232112710","article-title":"Specificities of the DMD gene mutation spectrum in Russian patients","volume":"23","author":"Zinina","year":"2022","journal-title":"Int. Journal Molecular Sciences"}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1805459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:10:26Z","timestamp":1781820626000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1805459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":28,"alternative-id":["10.3389\/fgene.2026.1805459"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1805459","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"article-number":"1805459"}}